本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cogent Biosciences, Inc.

10.86
-0.1100-1.00%
盘后10.860.00000.00%17:14 EDT
成交量:173.21万
成交额:1,856.05万
市值:15.18亿
市盈率:-4.31
高:10.97
开:10.87
低:10.38
收:10.97
52周最高:12.97
52周最低:3.72
股本:1.40亿
流通股本:9,913.91万
量比:0.92
换手率:1.75%
股息:- -
股息率:- -
每股收益(TTM):-2.5207
每股收益(LYR):-2.4616
净资产收益率:-84.04%
总资产收益率:-47.45%
市净率:13.70
市盈率(LYR):-4.41

数据加载中...

2022/06/10

重要事件披露

8-K - Current report
2022/05/20

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/10

重要事件披露

8-K - Current report
2022/05/06

重要事件披露

8-K - Current report
2022/03/17

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/15

重要事件披露

8-K - Current report
2022/03/01

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/25

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/27

重要事件披露

8-K - Current report
2021/10/05

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股变动声明

4 - Statement of changes in beneficial ownership of securities